Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PA2242 - Provider product page
- Provider
- Boster Biological Technology
- Product name
- Anti-RIP3/RIPK3 Antibody
- Antibody type
- Polyclonal
- Description
- Polyclonal antibody for RIP3/RIPK3 detection. Host: Rabbit.Size: 100μg/vial. Tested applications: WB. Reactive species: Human. RIP3/RIPK3 information: Molecular Weight: 56887 MW; Subcellular Localization: Cytoplasm, cytosol . Cell membrane . Mitochondrion ; Tissue Specificity: Highly expressed in the pancreas. Detected at lower levels in heart, placenta, lung and kidney. Isoform 3 is significantly increased in colon and lung cancers.
- Reactivity
- Human
- Host
- Rabbit
- Vial size
- 100μg/vial
- Concentration
- Add 0.2ml of distilled water will yield a concentration of 500ug/ml.
- Storage
- At -20°C for one year. After reconstitution, at 4°C for one month. It can also be aliquoted and stored frozen at -20°C for a longer time. Avoid repeated freezing and thawing.
- Handling
- Add 0.2ml of distilled water will yield a concentration of 500ug/ml.
Submitted references Regulators of calcineurin 1 deficiency attenuates tubulointerstitial fibrosis through improving mitochondrial fitness.
Jujuboside B promotes the death of acute leukemia cell in a RIPK1/RIPK3/MLKL pathway-dependent manner.
Conditional knockout of TGF-βRII /Smad2 signals protects against acute renal injury by alleviating cell necroptosis, apoptosis and inflammation.
Sang XY, Xiao JJ, Liu Q, Zhu R, Dai JJ, Zhang C, Yu H, Yang SJ, Zhang BF
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2020 Nov;34(11)
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2020 Nov;34(11)
Jujuboside B promotes the death of acute leukemia cell in a RIPK1/RIPK3/MLKL pathway-dependent manner.
Jia MM, Li YQ, Xu KQ, Zhang YY, Tan SM, Zhang Q, Peng J, Luo XJ
European journal of pharmacology 2020 Jun 5;876:173041
European journal of pharmacology 2020 Jun 5;876:173041
Conditional knockout of TGF-βRII /Smad2 signals protects against acute renal injury by alleviating cell necroptosis, apoptosis and inflammation.
Yang Q, Ren GL, Wei B, Jin J, Huang XR, Shao W, Li J, Meng XM, Lan HY
Theranostics 2019;9(26):8277-8293
Theranostics 2019;9(26):8277-8293
No comments: Submit comment
No validations: Submit validation data